# K141926: Invia Endure Negative Pressure Wound Therapy System

- Pathway: 510(k) (Traditional)
- Applicant: Medela AG
- Decided: Dec 19, 2014 after 156 days
- Product code: OMP (Negative Pressure Wound Therapy Powered Suction Pump)
- Device class: 2
- Regulation: 21 CFR 878.4780
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K945062 (1995). 21 ancestors in all.
5 later devices descend from it; 1 cites it directly.
0 of 27 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K080357: Medela Invia Wound Therapy, Medela AG (2008) Summary page 4.
- K113678: Invia Motion Negative Pressure Wound Therapy System, Medela AG (2012) Summary page 4.

## Most influential descendants
- K161128: Invia Motion-Endure Negative Pressure Wound Therapy System, Invia Motion-7-120 Days Negative Pressure Wound Therapy System, Invia Motion Canister/Tubing Set 0.151, Invia Motion Carrying Case, Power Supply (2016), 4 descendants of its own
- K172145: Invia Foam Dressing Kits With FitPad, Invia Motion Negative Pressure Wound Therapy System (Invia Motion - Endure, Invia Motion – 120 days, Invia Motion – 60 days, Invia Motion – 30 days, Invia Motion – 15 days, Invia Motion – 7 days), Invia Liberty Negative Pressure Wound Therapy System, Invia Gauze Dressing Kits with FitPad (2018), 3 descendants of its own
- K254019: Wound Geni NPWT System (2026), 0 descendants of its own
- K223388: Invia® Integrated Dressing (2023), 0 descendants of its own
- K214112: Invia Ease Negative Pressure Wound Therapy (NPWT) System (2022), 0 descendants of its own

## Indications for use
The portable Medela Invia Endure Negative Pressure Wound Therapy (NPWT) system is indicated to create an environment that promotes wound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfusion, and by removing exudates and infectious material. It is intended for the use in hospitals, clinics, Long Term Care (LTC) and Home Care (HC) settings on adult patients with chronic, acute, subacute, traumatic, dehisced wounds, partial-thickness burns, ulcers (such as diabetic, neuropethic, pressure or venous insufficiency), flaps and grafts.

Source page: https://510kreport.com/device/K141926
Methodology: https://510kreport.com/methodology